January 9, 2025 - 02:52

Quantum computing stocks faced a steep decline on Wednesday as industry leader Jensen Huang, CEO of Nvidia, expressed skepticism about the near-term viability of practical quantum computers. Huang's assertion that "useful quantum computers" are still approximately 20 years away sent shockwaves through the market, leading to massive sell-offs among key players in the sector.
Rigetti Computing, IonQ Inc., and Quantum Computing saw their stock prices plummet by over 40% during the trading session, reflecting investor concerns about the long timeline for quantum technology to become commercially viable.
The fallout from Huang's comments has left investors reevaluating their positions within the quantum computing space, raising questions about the future of this emerging technology. As the market reacts, other companies such as D-Wave Quantum Inc. and Vir Biotechnology, Inc. are also catching attention, indicating a broader shift in focus among investors. The uncertainty surrounding quantum computing continues to loom large, with industry experts weighing in on the implications of these developments.
April 24, 2026 - 03:53
Fulton Financial Narrative Shifts as Deal Synergies Drive $24 Price TargetFulton Financial Corporation is drawing renewed attention from analysts as the narrative surrounding the bank shifts toward acquisition-driven growth, with a price target now set at $24 per share....
April 23, 2026 - 19:29
Amex CEO: Customers Are 'Rolling With' Inflation and Higher Gas Prices as Travel Demand SurgesAmerican Express posted blowout quarterly earnings that beat Wall Street expectations, driven by record-high spending from its affluent cardmembers. Despite persistent inflation and gas prices...
April 23, 2026 - 04:11
6 smart retirement moves to make in your 20s to help you get aheadWhile many Americans report declining confidence in their retirement savings, young adults have a powerful tool on their side: time. Starting financial planning in your twenties can dramatically...
April 22, 2026 - 01:31
ADOCIA and Vester Finance sign a shareholder loan agreement, enabling ADOCIA to extend its cash runway until beginning Q2 2027LYON, France, April 21, 2026 -- Adocia, a clinical-stage biopharmaceutical company developing treatments for diabetes and obesity, has announced a strategic financial agreement with Vester Finance....